Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island
AB-RUN
1 other identifier
observational
500
1 country
1
Brief Summary
In its report dated april 2014, World Health Organization confirms antibiotic resistance dissemination in all parts of the world, in hospitals and in community and worries about a possible comeback to a pre-antibiotic era during the 21st century. For the last 15 years, third-generation cephalosporins resistant enterobacteriaceae (3GCREB) prevalence is continuously increasing. Community 3GCREB prevalence has not been studied whereas several observations made in Reunion Island hospital suggest a diffusion in community. In this situation of world-wide and regional extension of bacterial resistance, the investigator offers to study bacterial resistance to antibiotic in Reunion Island community.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2017
CompletedFirst Posted
Study publicly available on registry
July 21, 2017
CompletedStudy Start
First participant enrolled
November 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedMarch 7, 2019
March 1, 2019
1 year
March 3, 2017
March 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Digestive prevalence rate of 3GCREB
estimate of digestive prevalence rate of 3GCREB in participating patients and extrapolation to Reunion Island community population.
through study completion, an average of 1 day
Study Arms (1)
stool sampled community patients
community patients entering emergency ward or intensive care unit in Reunion Island university hospital and having the stools sampled for bacterial analysis.
Interventions
study will be proposed to all patients entering emergency ward or intensive care unit in Reunion Island university hospital. Upon consent, a stool sample will be taken (either directly on emitted stools or by rectal sampling) and analysed for enterobacteriaceae.
Eligibility Criteria
community patients admitted in emergency ward or in intensive care unit for any condition.
You may qualify if:
- Patients:
- aged over 18 years old
- admitted in emergency ward or intensive care of the university hospital of Reunion Island
- who received the patient information notice and who gave their consent
- who have a stool sample performed in the 48 hours following admission
- who understand and can read French
You may not qualify if:
- Patients:
- transferred from a short-term, middle-term or long-term stay health facility
- who have a stool sample performed more than 48 hours following admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Reunion Island
Saint-Pierre, Reunion Island, 97410, Reunion
Biospecimen
stools samples
Study Officials
- PRINCIPAL INVESTIGATOR
Julien JAUBERT, MD
CHU La Réunion
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2017
First Posted
July 21, 2017
Study Start
November 21, 2017
Primary Completion
December 1, 2018
Study Completion
June 30, 2019
Last Updated
March 7, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share